Atopic eczema: what's new?

Atopic eczema (AE) is a chronic inflammatory skin disease characterized by recurrent intense pruritus and a typical age‐related distribution of skin lesions. Several new aspects with regard to the pathogenetic background as well as strategies for prevention, diagnosis and treatment of AE have emerge...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2006-05, Vol.20 (5), p.503-513
Main Authors: Möhrenschlager, M, Darsow, U, Schnopp, C, Ring, J
Format: Article
Language:English
Subjects:
Animals
atopic
dermatitis
Dermatitis, Atopic - diagnosis
Dermatitis, Atopic - etiology
Dermatitis, Atopic - prevention & control
Dermatitis, Atopic - therapy
Diagnosis, Differential
eczema
Humans
Patch Tests
Patient Education as Topic
Prognosis
Risk Factors
Terminology as Topic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atopic eczema (AE) is a chronic inflammatory skin disease characterized by recurrent intense pruritus and a typical age‐related distribution of skin lesions. Several new aspects with regard to the pathogenetic background as well as strategies for prevention, diagnosis and treatment of AE have emerged. There are ongoing studies on genetic susceptibility loci, as well as environmental and nutritional factors associated with an increase or a decrease of AE lesions. The atopy patch test is now available for identification of allergens in aeroallergen‐triggered AE. New topical therapies, such as the calcineurin inhibitors, have broadened the therapeutic armamentarium substantially. In order to increase knowledge and coping strategies, patient education programs have been launched. Learning objective  Upon completing this paper, the reader should be aware of new developments in AE, especially on nomenclature, prevention strategies, diagnostic tests, as well as therapeutic options.
ISSN:0926-9959
1468-3083
DOI:10.1111/j.1468-3083.2006.01580.x